Key Sessions
Andreas Vegge, PhD
Amycretin - A Unimolecular GLP-1 and Amylin Receptor Agonist - From Discovery to Clinical Proof of Concept
Novo Nordisk
Late Breaking Keynote
Shalini Andersson, PhD
Expanding the Druggable Target Space in the Heart with Cardiomyocyte Targeted Oligonucleotides
AstraZeneca
Peter't Hart, PhD
Peptide Modulators of mRNA Processing
University of Münster
Brendan Frey, PhD
AI’s Next Frontier in Pharma: Foundation Models
Deep Genomics
Pre-Conference Workshops (am) &Main Conference Day 1 Plenary (pm) - CET (Central European Time, GMT+01:00)
Pre-Conference Workshops (am) &Main Conference Day 1 Plenary (pm)
- CET (Central European Time, GMT+01:00)
08:30 - 09:0030 mins
Registration and Coffee
Optional Pre-Conference Morning Workshops: 9.00am-12.00pm
09:00 - 09:055 mins
Workshop #1: Oligonucleotide Manufacturing and CMC Efficiencies and Control Strategies
Workshop Co-Moderators’ Welcome and Opening Remarks
- Thomas Rupp - Owner & Principal, Thomas Rupp Consulting AG
- Sonja Merkas, PhD - Founder, Creator and Doer, Livinovea
09:00 - 09:055 mins
Workshop #2: Digital Innovation and Technology in Oligonucleotide Development
Workshop Moderator's Welcome and Opening Remarks
- Nadim Akhtar, PhD - Principal Scientist, AstraZeneca
09:00 - 09:055 mins
Workshop #3: Innovations and Challenges in Peptide Manufacturing
Moderator’s Welcome and Opening Remarks
- Bruce Morimoto, PhD - Independent Consultant, TIDES Advisor
09:05 - 09:4540 mins
Workshop #1: Oligonucleotide Manufacturing and CMC Efficiencies and Control Strategies
Integrating Manufacturing and Operations in Oligonucleotide CMC
- Sonja Merkas, PhD - Founder, Creator and Doer, Livinovea
09:05 - 09:2015 mins
Workshop #2: Digital Innovation and Technology in Oligonucleotide Development
Leveraging Digital to Accelerate Oligonucleotide Development
- Nadim Akhtar, PhD - Principal Scientist, AstraZeneca
09:05 - 09:4035 mins
Workshop #3: Innovations and Challenges in Peptide Manufacturing
Challenges of Raw Material Acquisition for Peptide Synthesis
- Robert Hagopian - Director Business Development, PolyPeptide Group
09:20 - 09:5535 mins
Workshop #2: Digital Innovation and Technology in Oligonucleotide Development
Digital Innovations in Oligonucleotide Manufacturing
- Barrie Cassey, PhD - Medicines Manufacturing Technology Director, CPI
09:40 - 10:1535 mins
Workshop #3: Innovations and Challenges in Peptide Manufacturing
Crystallisation as a Purification (and IP-extension) Strategy in Peptide Manufacturing
- Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
09:45 - 10:2540 mins
Workshop #1: Oligonucleotide Manufacturing and CMC Efficiencies and Control Strategies
Challenges in Upscaling Manufacturing Processes
- Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
09:55 - 10:3035 mins
Workshop #2: Digital Innovation and Technology in Oligonucleotide Development
SubQ-Sim: A Physiologically-Based Biopharmaceutical Model (PBBM) for Advancing Oligonucleotide Subcutaneous Drug Delivery
- Ross Kelly, PhD - Associate Principal Scientist, AstraZeneca
10:15 - 10:5035 mins
Workshop #3: Innovations and Challenges in Peptide Manufacturing
Networking Refreshment Break
10:25 - 10:5025 mins
Workshop #1: Oligonucleotide Manufacturing and CMC Efficiencies and Control Strategies
Networking Refreshment Break
10:30 - 11:0030 mins
Workshop #2: Digital Innovation and Technology in Oligonucleotide Development
Networking Refreshment Break
10:50 - 11:3040 mins
Workshop #1: Oligonucleotide Manufacturing and CMC Efficiencies and Control Strategies
Process-related Impurities, Their Origin and How to Control Them
- Thomas Rupp - Owner & Principal, Thomas Rupp Consulting AG
10:50 - 11:2535 mins
Workshop #3: Innovations and Challenges in Peptide Manufacturing
Innovations in Downstream Processing and Purification
- Marc Jacob, PhD - Head of Strategic Development, Chromatography Products, YMC America
11:00 - 11:3030 mins
Workshop #2: Digital Innovation and Technology in Oligonucleotide Development
Data-Driven Oligonucleotide Development: Integrating Process, Synthesis, and Analytical Insights
- Martin Olbrich, PhD - Head of Process Chemistry 3, F Hoffmann-La Roche Ltd.
- Guido Creusen, PhD - Senior Scientist, Synthetic Molecules Technical, F. Hoffmann-La Roche Ltd.
11:25 - 12:0035 mins
Workshop #3: Innovations and Challenges in Peptide Manufacturing
Peptide Manufacturing Case Study
11:30 - 12:0030 mins
Workshop #1: Oligonucleotide Manufacturing and CMC Efficiencies and Control Strategies
Q&A Panel Discussion with Workshop Speakers
11:30 - 12:0030 mins
Workshop #2: Digital Innovation and Technology in Oligonucleotide Development
How Mechanistic Modeling Can Alleviate Challenges from Process Development to Scale-up of Oligonucleotides
- Philipp Weber - Junior Scientist, F. Hoffmann-La Roche AG
- Lucrece Nicoud, PhD - Co-CEO, Ypso-Facto
Luncheon Spotlight Presentations (for Morning Workshop Attendees Only)
12:00 - 12:1515 mins
Luncheon Spotlight Presentation 1
Transition to Lunch Spotlight Presentation
12:00 - 12:1515 mins
Luncheon Spotlight Presentation 2
Transition to Lunch Spotlight Presentation
12:15 - 12:4530 mins
Luncheon Spotlight Presentation 1
Decoding the Structures of Peptides and Oligonucleotides through Innovative Technology
- Victor Beaumont, PhD - Strategic Market Development Specialist, Bruker UK Limited
12:15 - 12:4530 mins
Luncheon Spotlight Presentation 2
Chemoenzymatic Ligation: Advancing Next-Generation Manufacturing Technologies for siRNA and sgRNA
- David Butler, PhD - Chief Technology Officer, Hongene Biotech Corporation
12:45 - 13:1025 mins
Luncheon Spotlight Presentation 1
Short Break and Transition to Keynote Session
12:45 - 13:1025 mins
Luncheon Spotlight Presentation 2
Short Break and Transition to Keynote Sessions
13:10 - 13:155 mins
Keynote Sessions - MAIN CONFERENCE
Chairperson’s Remarks
13:15 - 13:5035 mins
Keynote Sessions - MAIN CONFERENCE
Expanding the Druggable Target Space in the Heart with Cardiomyocyte Targeted Oligonucleotides
- Shalini Andersson, PhD - Vice President of Oligonucleotide Discovery, AstraZeneca
13:50 - 14:2535 mins
Keynote Sessions - MAIN CONFERENCE
Peptide Modulators of mRNA Processing
- Peter't Hart, PhD - Professor of Molecular Biochemistry, University of Münster
14:25 - 15:0035 mins
Keynote Sessions - MAIN CONFERENCE
AI’s Next Frontier in Pharma: Foundation Models
- Brendan Frey, PhD - Founder and Chief Innovation Officer, Deep Genomics
15:00 - 15:5050 mins
Networking Refreshment Break in Poster and Exhibit Hall
15:50 - 16:2535 mins
Keynote Sessions - MAIN CONFERENCE
Amycretin - A Unimolecular GLP-1 and Amylin Receptor Agonist - From Discovery to Clinical Proof of Concept
- Andreas Vegge, PhD - Project Vice President, Amycretin Cardiometabolics, Novo Nordisk
16:25 - 17:0035 mins
Keynote Sessions - MAIN CONFERENCE
Late Breaking Keynote
17:00 - 18:3090 mins
Networking Reception in Poster and Exhibit Hall
18:30 - 18:355 mins
Close of Day One
* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.